NLM Gateway
A service of the U.S. National Institutes of Health
Your Entrance to
Resources from the
National Library of Medicine
    Home      Term Finder      Limits/Settings      Search Details      History      My Locker        About      Help      FAQ    
Skip Navigation Side Barintended for web crawlers only
 

An Open Design Study to Determine Subject Treatment Preference of Once Daily Valacyclovir as Suppressive Therapy Versus Valacyclovir Twice Daily Episodic Treatment for Recurrent Genital Herpes Infections.

ROMANOWSKI B, GRANT ZA, TABACK N; Interscience Conference on Antimicrobial Agents and Chemotherapy; THE VALACYCLORIR STUDY GRP.

Abstr Intersci Conf Antimicrob Agents Chemother Intersci Conf Antimicrob Agents Chemother. 2000 Sep 17-20; 40: 265.

Univ. of Alberta, Edmonton, AB, Canada

BACKGROUND: This study was designed to evaluate & test the hypothesis that subjects prefer valacyclovir suppressive therapy versus episodic therapy for the management of recurrent genital herpes (GH).METHODS: A prospective, open-label cross-over study was conducted in 16 centres across Canada in adult subjects with recurrent GH. Subjects with >/= 3 to

Publication Types:
  • Meeting Abstracts
Keywords:
  • Acyclovir
  • Adult
  • Antiretroviral Therapy, Highly Active
  • Canada
  • Female
  • Herpes Genitalis
  • Humans
  • Longitudinal Studies
  • Male
  • Recurrence
  • Treatment Outcome
  • Valine
  • drug therapy
  • therapy
  • valacyclovir
Other ID:
  • GWAIDS0010186
UI: 102247684

From Meeting Abstracts




Contact Us
U.S. National Library of Medicine |  National Institutes of Health |  Health & Human Services
Privacy |  Copyright |  Accessibility |  Freedom of Information Act |  USA.gov